Vimarsana
Biggest News Aggregation in the World

Page 3 - Precision Medicine Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Medicine Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Medicine Program Today - Breaking & Trending Today

Six U-M researchers receive Biosciences Initiative award for excellence among mid-career faculty - Vimarsana News

Six U-M researchers receive Biosciences Initiative award for excellence among mid-career faculty

Six University of Michigan scientists and engineers have been named the 2022 winners of the MBioFAR Award, which recognizes exceptional mid-career faculty in the biosciences. MBioFAR, which stands for Mid-career Biosciences Faculty Achievement Recognition, is an annual award established last year

Source: umich.edu
Catie's Gathering raises funds for childhood cancer research - Vimarsana News

Catie's Gathering raises funds for childhood cancer research

MOULTRIE, Ga. – CURE, an Atlanta-based non-profit organization, recently hosted an inaugural Catie’s Gathering event in Moultrie to raise funds for childhood cancer research.

GO2 Foundation for Lung Cancer to Honor Dr. Rafael Rosell with the Bonnie J. Addario Lectureship Award - Vimarsana News

GO2 Foundation for Lung Cancer to Honor Dr. Rafael Rosell with the Bonnie J. Addario Lectureship Award

/PRNewswire/ -- GO2 Foundation for Lung Cancer announced today that it will present Dr. Rafael Rosell with the 2022 Bonnie J. Addario Lectureship Award for his...

Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial | Business - Vimarsana News

Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial | Business

LARKSPUR, Calif.--(BUSINESS WIRE)--Jul 6, 2022--

Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial - Vimarsana News

Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial

Biohaven and Vigeo Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial to Evaluate Interventions for Patients With GlioblastomaLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA), Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), and V...